Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody

医学 抢救性手术 肝细胞癌 挽救疗法 内科学 外科 肿瘤科 化疗 放射治疗
作者
Lei Wang,Jin-Kai Feng,Chong‐De Lu,Jiayi Wu,Bin Zhou,Kang Wang,Xubiao Wei,Chao Liang,Hongkun Zhou,Jie Shi,Wei‐Xing Guo,Wan Yee Lau,Mao-Lin Yan,Shuqun Cheng
出处
期刊:Oncologist [AlphaMed Press]
卷期号:29 (8): e1041-e1050 被引量:14
标识
DOI:10.1093/oncolo/oyae032
摘要

BACKGROUND: This study aimed to compare the survival outcomes of patients with initially unresectable hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) who underwent or did not undergo salvage surgery followed by a triple combination conversion treatment consisted of locoregional treatment (LRT), tyrosine kinase inhibitors (TKIs), and anti-PD-1 antibodies. METHODS: The data from 93 consecutive patients with initially unresectable HCC and PVTT across 4 medical centers were retrospectively reviewed. They were converted successfully by the triple combination treatment and underwent or did not undergo salvage resection. The baseline characteristics, conversion schemes, conversion treatment-related adverse events (CTRAEs), overall survival (OS), and progression-free survival (PFS) of the salvage surgery and non-surgery groups were compared. Multivariate Cox regression analysis was performed to identify independent risk factors for OS and PFS. Additionally, subgroup survival analysis was conducted by stratification of degree of tumor response and type of PVTT. RESULTS: Of the 93 patients, 44 underwent salvage surgery, and 49 did not undergo salvage surgery. The OS and PFS of the salvage surgery and non-surgery groups were not significantly different (P = .370 and .334, respectively). The incidence and severity of CTRAEs of the 2 groups were also comparable. Subgroup analyses revealed that for patients with complete response (CR) or types III-IV PVTT, there was a trend toward better survival in patients who did not undergo salvage surgery. Multivariate analysis showed that baseline α-fetoprotein and best tumor response per mRECIST criteria were independent prognostic factors for OS and PFS. CONCLUSIONS: For patients with initially unresectable HCC and PVTT who were successfully converted by the triple combination therapy, salvage liver resection may not be necessary, especially for the patients with CR or types III-IV PVTT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
WiseHuman2007完成签到,获得积分10
刚刚
琪琪完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
2秒前
快乐的乘风完成签到,获得积分10
2秒前
水天需完成签到,获得积分10
2秒前
WiseHuman2007发布了新的文献求助10
2秒前
haoyun驳回了李健的应助
3秒前
AfVin完成签到,获得积分10
4秒前
Jasper的应助被风韵犹存采纳,获得10
4秒前
一块麻糖发布了新的文献求助10
5秒前
田様的应助被爱吃香菜采纳,获得10
6秒前
wang发布了新的文献求助10
6秒前
水天需发布了新的文献求助10
6秒前
天天快乐的应助被GARYJIANG采纳,获得10
6秒前
Yang发布了新的文献求助10
7秒前
Thi发布了新的文献求助10
7秒前
刘可为关注了科研通微信公众号
7秒前
8秒前
aaa发布了新的文献求助10
8秒前
幽默的乐双完成签到,获得积分10
8秒前
初景发布了新的文献求助10
9秒前
CipherSage的应助被TGU采纳,获得10
9秒前
10秒前
隐形曼青的应助被科研通管家采纳,获得10
10秒前
NexusExplorer的应助被科研通管家采纳,获得30
10秒前
orixero的应助被科研通管家采纳,获得10
11秒前
11秒前
JamesPei的应助被科研通管家采纳,获得10
11秒前
英俊的铭的应助被科研通管家采纳,获得10
11秒前
Nole的应助被科研通管家采纳,获得10
11秒前
爆米花的应助被科研通管家采纳,获得10
11秒前
11秒前
科研通AI2S的应助被shg采纳,获得10
11秒前
11秒前
共享精神的应助被科研通管家采纳,获得10
11秒前
12秒前
英俊的铭的应助被科研通管家采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158056
求助须知:如何正确求助?哪些是违规求助? 9553944
关于积分的说明 21716733
捐赠科研通 7747388
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551676
邀请新用户注册赠送积分活动 2471038